You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Aflibercept solution for injection for treating wet age‑related macular degeneration

  • Technology appraisal guidance
  • Reference number: TA294
  • Published:  24 July 2013
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Related NICE guidance
  • 7 Review of guidance
  • 8 Appraisal Committee members and NICE project team
  • 9 Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance

6 Related NICE guidance

  • Epiretinal brachytherapy for wet age related macular degeneration. NICE interventional procedure guidance 415 (2011).

  • Macular translocation with 360° retinotomy for wet age\u2011\related macular degeneration. NICE interventional procedure guidance 340 (2010).

  • Limited macular translocation for wet age\u2011\related macular degeneration. NICE interventional procedure guidance 339 (2010).

  • Implantation of miniature lens systems for advanced age\u2011\related macular degeneration. NICE interventional procedure guidance 272 (2008).

  • Ranibizumab and pegaptanib for the treatment of age\u2011\related macular degeneration. NICE technology appraisal guidance 155 (2008).

  • Transpupilary thermotherapy for age\u2011\related macular degeneration. NICE interventional procedure guidance 58 (2004).

  • Radiotherapy for age\u2011\related macular degeneration. NICE interventional procedure guidance 49 (2004).

  • Guidance on the use of photodynamic therapy for age\u2011\related macular degeneration. NICE technology appraisal guidance 68 (2003).


Next page 7 Review of guidance Previous page 5 Implementation